- Report
- April 2024
- 137 Pages
Global
From €2875EUR$2,999USD£2,402GBP
- Report
- April 2023
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Book
- March 2012
- 472 Pages
The Protein Pharmaceutical market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Proteins are essential components of all living organisms, and are involved in a variety of biological processes. Protein Pharmaceuticals are drugs that are derived from proteins, and are used to treat a variety of diseases and conditions. These drugs are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. Protein Pharmaceuticals are often used to treat cancer, autoimmune diseases, and other chronic conditions.
The Protein Pharmaceutical market is highly competitive, with a number of companies vying for market share. Some of the major players in the market include Amgen, Biogen, Genentech, Merck, Novartis, and Pfizer. Show Less Read more